Shareholders of Haleos Labs Limited approved the reappointment of Mrs. Sudeepthi Gopineedi as Whole-time Director but rejected a special resolution concerning managerial remuneration for Executive Directors.

The postal ballot process, which concluded on August 28, 2026, saw three of the four proposed resolutions pass with requisite majorities. The rejected resolution sought approval for payment of managerial remuneration pursuant to Regulation 17(6)(e) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Results

The voting results, scrutinized by C. Sudhir Babu of CSB Associates, reveal distinct shareholder sentiment across the agenda items. While the reappointment and related party transaction approvals enjoyed near-unanimous support from voting public shareholders, the remuneration proposal faced significant opposition.

The reappointment of Mrs. Gopineedi for a further period of five years received 99.99% support from valid votes cast. Similarly, the ordinary resolutions approving material related party transactions for both the company and its material subsidiary for FY27 passed with over 99.98% affirmative votes.

What the Numbers Show

The failure of the managerial remuneration resolution was driven by substantial opposition from the promoter group. The scrutinizer's report notes that 4,83,612 votes cast by the promoter group against the remuneration resolution were counted as valid, whereas identical vote counts from the same group were marked invalid for the other resolutions due to interest conflicts.

While public non-institutional shareholders voted 90.81% in favor of the remuneration package, the promoter group’s unified opposition—comprising 82.16% of all valid votes cast on this specific item—prevented the special resolution from achieving the necessary majority. This divergence highlights a clear split between promoter interests and public shareholder preferences regarding executive compensation limits.

The resolutions passed are deemed effective as of August 28, 2026. The company has uploaded the detailed voting results and scrutinizer’s report on its website and the Central Depository Services (India) Limited platform.

Haleos Labs Limited has recommended a final dividend of ₹1.50 per equity share for the financial year ended March 31, 2026 (FY26). The payout represents a 15% dividend on the face value of ₹10 per share.

The Board of Directors approved the recommendation during its meeting held on May 29, 2026. Shareholders must approve the dividend at the company’s 20th Annual General Meeting (AGM) before the payout is finalized.

Record Date and Payment

The record date for determining eligibility is September 23, 2026. Shareholders whose names appear in the Register of Members as at the close of business on this date will receive the dividend.

Payments will be made electronically to shareholders with registered bank accounts. Those without updated bank details will receive dividend warrants or demand drafts via post.

Tax Deduction at Source

Dividend income is taxable under the Income Tax Act, 2025. Haleos Labs will deduct Tax Deduction at Source (TDS) based on shareholder category and documentation.

Shareholders must submit necessary declarations, including Form 121 for tax exemption, by September 25, 2026. Failure to provide valid documentation may result in higher TDS rates.

What the Numbers Show

The declared dividend of ₹1.50 per share implies a total payout liability dependent on the outstanding equity capital. With no revenue or profit figures disclosed in this specific communication, the dividend yield cannot be calculated against current earnings. The focus remains on regulatory compliance for tax withholding rather than operational performance metrics.